Evidence map›Paper›PMID 31934058›Full record

ArticleInternational journal of clinical and experimental pathology2019

Malignant solitary fibrous tumor of the liver: a case report.

Qiang Shu, Xiaoling Liu, Xiaoli Yang, Bing Guo, Tao Huang, Hong Lei, Fangyi Peng, Song Su, Bo Li

Open access · greenAbstract readCase Reports
In one paragraph

Article in International journal of clinical and experimental pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Qiang ShuDepartment of Hepatobiliary Surgery, The Affiliated Hospital of Southwest Medical University Luzhou, Sichuan Province, P. R. China.
Xiaoling LiuDepartment of Hepatobiliary Surgery, The Southwest Medical University Luzhou, Sichuan Province, P. R. China.
Xiaoli YangDepartment of Hepatobiliary Surgery, The Affiliated Hospital of Southwest Medical University Luzhou, Sichuan Province, P. R. China.
Bing GuoDepartment of Hepatobiliary Surgery, The Affiliated Hospital of Southwest Medical University Luzhou, Sichuan Province, P. R. China.
Tao HuangDepartment of Hepatobiliary Surgery, The Affiliated Hospital of Southwest Medical University Luzhou, Sichuan Province, P. R. China.
Hong LeiDepartment of Pathology, The Affiliated Hospital of Southwest Medical University Luzhou, Sichuan Province, P. R. China.
Fangyi PengDepartment of Hepatobiliary Surgery, The Affiliated Hospital of Southwest Medical University Luzhou, Sichuan Province, P. R. China.
Song SuDepartment of Hepatobiliary Surgery, The Affiliated Hospital of Southwest Medical University Luzhou, Sichuan Province, P. R. China.
Bo LiDepartment of Hepatobiliary Surgery, The Affiliated Hospital of Southwest Medical University Luzhou, Sichuan Province, P. R. China.
Affiliated Hospital of Southwest Medical University · CNSouthwest Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSolitary fibrous tumor (SFT) is a rare mesenchymal tumor. Due to the rarity of malignant solitary fibrous tumor of the liver, information regarding the disease is currently limited. We present herein a case of malignant liver SFT in a 17-year-old female, who was misdiagnosed with hepatoblastoma preoperatively. CASE REPORT: A 17-year-old female who was diagnosed with hepatoblastoma preoperatively The patient presented with pain in the upper abdomen and an abdominal mass. Tumor markers were normal and imaging findings were atypical. The tumor was successfully removed by surgery. Postoperative pathological examination and immunohistochemistry confirmed malignant solitary fibrous tumor. The patient recovered uneventfully and is disease-free without recurrence at the time of this report (14 months post-surgery).

conclusionSFT originates in the liver and is a rare tumor. Differential diagnosis should be considered for liver lesions with atypical imaging findings. More data are needed to understand the disease's long-term outcome and identify clinical and radiologic features that can be useful for its diagnosis. The best choice for treatment is complete surgical resection, and definitive diagnosis based on histologic and immunohistochemical characteristics. Tumor biology is unclear, and long-term follow-up of SFT patients is critical.

Indexed as

liverMalignantmesenchymal neoplasmsolitary fibrous tumorsurgical resection

Identifiers

PMID31934058
PMCPMC6949633
OpenAlexW3005107113

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.